Sök artiklar i SveMed+

Observera: SveMed+ upphör att uppdateras!



Cannabis og glaukom
Engelsk titel: Should ophtalmologists recommend medical cannabis to patients with glaucoma? Läs online Författare: Mouhammad, Zaynab Ahmad ; Kolko, Miriam Språk: Dan Antal referenser: 29 Dokumenttyp: Översikt UI-nummer: 19050119

Tidskrift

Ugeskrift for Laeger 2019;181(5)424-8 ISSN 0041-5782 E-ISSN 1603-6824 KIBs bestånd av denna tidskrift Denna tidskrift är expertgranskad (Peer-Reviewed)

Sammanfattning

Cannabis has been widely used for various medical purposes since before year 2000 BC. Its effects are mediated by cannabinoids and stimulation of mainly G-protein coupled cannabinoid receptors. In 1971, subjects who smoked marihuana, showed a decrease in the intraocular pressure. Later investigations additionally revealed a neuroprotective effect of both ∆-9-tetrahydrocannabinol and cannabidiol (CBD). Furthermore, CBD was found to promote neurogenesis. The aim of this review is to provide an overview of the potential use of cannabinoids in the treatment of glaucoma.